Detecting womb and ovarian cancers with a vaginal sample
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests a new device that collects a sample from the vagina to look for signs of womb (endometrial) or ovarian cancer. It may offer a simpler way to check for these cancers compared to current methods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You can give your informed consent to take part.
- You are already seeing a gynecology specialist (secondary care).
- You are able to have a speculum exam (like a Pap smear) or use a tampon.
- You have not had your uterus removed (hysterectomy).
- You are not pregnant or suspect you might be pregnant.
- You have no allergies to the materials used in the device (polypropylene, nylon, nitrile, or barrier contraception).
- You have not had pelvic radiation in the last 6 weeks, or chemotherapy, immunotherapy, or new cancer drugs in the last 3 weeks.
- You do not have certain infections (like hepatitis B or C, HIV, HTLV-II, or prion diseases).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether collecting samples using tampons can help detect endometrial and ovarian cancers in people who are already scheduled for certain gynecologic surgeries. It may help researchers improve future early detection tests.
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
This study tests whether a transvaginal ultrasound can be used as a screening tool for ovarian cancer in women at higher risk. It may help find ovarian cancer earlier in people who have a strong family or personal cancer history.
This study tests a simple, non-invasive method to detect endometrial cancer in women after menopause who have abnormal bleeding. It aims to find cancer early in those at higher risk, such as women with certain genetic conditions or risk factors.
This laboratory study uses ovarian cancer fluid collected during surgery to test possible new treatments on cancer and immune cells. It may help researchers find better treatment options in ovarian cancer.
This study uses lab testing to create a “map” of ovarian cancer cells one cell at a time, to better understand the disease. It likely helps researchers learn which cell types are involved, using samples collected around your surgery.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.